Skip to main content

Kodiak Sciences Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

KOD$108.06+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’
Shares · Amount · Capital · Income (Loss) · Deficit · Equity
Balances at December 31, 202352,508,602$5$1,418,307$—$(1,152,531)$265,781
Issuance of common stock upon exercise of stock options8,333—38——38
Issuance of common stock upon vesting of restricted stock units6,512—————
Stock-based compensation expense——18,409——18,409
Net loss————(43,039)(43,039)
Balances at March 31, 202452,523,44751,436,754—(1,195,570)241,189
Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’
Shares · Amount · Capital · Income (Loss) · Deficit · Equity
Balances at December 31, 202252,333,850$5$1,329,509$(1,307)$(892,040)$436,167
Issuance of common stock upon exercise of stock options1,098—9——9
Issuance of common stock upon vesting of restricted stock units9,793—————
Stock-based compensation expense——25,980——25,980
Other comprehensive income———1,211—1,211
Net loss———(70,780)(70,780)
Balances at March 31, 202352,344,74151,355,498(96)(962,820)392,587
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.